newsfilter
← Latest News
Business Wire·

Genzyme Completes Sale of Diagnostics Business to Sekisui Chemical Co.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that it has completed the sale of its diagnostic products business to Sekisui Chemical Co., Ltd. for $265 million in cash.